Indantadol (BioDeep_00000179997)

   

human metabolite blood metabolite


代谢物信息卡片


2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide

化学式: C11H14N2O (190.1106074)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1C(CC2=CC=CC=C21)NCC(=O)N
InChI: InChI=1S/C11H14N2O/c12-11(14)7-13-10-5-8-3-1-2-4-9(8)6-10/h1-4,10,13H,5-7H2,(H2,12,14)

描述信息

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

同义名列表

4 个代谢物同义名

2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide; N-(2-Indanyl)glycinamide hydrochloride; N-(2-Indanyl)glycinamide; Indantadol



数据库引用编号

7 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Eric Woode, Wonder K M Abotsi. Antinociceptive effect of an ethanolic extract of the aerial parts of Hilleria latifolia (Lam.) H. Walt. (Phytolaccaceae). Journal of pharmacy & bioallied sciences. 2011 Jul; 3(3):384-96. doi: 10.4103/0975-7406.84445. [PMID: 21966159]
  • Consalvo Mattia, Flaminia Coluzzi. Indantadol, a novel NMDA antagonist and nonselective MAO inhibitor for the potential treatment of neuropathic pain. IDrugs : the investigational drugs journal. 2007 Sep; 10(9):636-44. doi: NULL. [PMID: 17786847]
  • Chantal Csajka, Bruno P Imbimbo, Annalisa Piccinno, Philippe Dostert, Davide Verotta. Mechanistic pharmacokinetic and pharmacodynamic modeling of CHF3381 (2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide monohydrochloride), a novel N-methyl-D-aspartate antagonist and monoamine oxidase-A inhibitor in healthy subjects. The Journal of pharmacology and experimental therapeutics. 2005 May; 313(2):647-57. doi: 10.1124/jpet.104.080457. [PMID: 15671203]
  • Béatrice Astruc, Antoine Tarral, Philippe Dostert, Fabrizia Mariotti, Laura Fabbri, Bruno P Imbimbo. Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects. British journal of clinical pharmacology. 2005 Apr; 59(4):405-14. doi: 10.1111/j.1365-2125.2005.02338.x. [PMID: 15801935]
  • Antoine Tarral, Philippe Dostert, Yann Guillevic, Laura Fabbri, Ivano Rondelli, Fabrizia Mariotti, Bruno P Imbimbo. Safety, pharmacokinetics, and pharmacodynamics of CHF 3381, a novel N-methyl-D-aspartate antagonist, after single oral doses in healthy subjects. Journal of clinical pharmacology. 2003 Aug; 43(8):901-11. doi: 10.1177/0091270003256137. [PMID: 12953347]
  • O Gandolfi, V Bonfante, M Voltattorni, R Dall'Olio, A Poli, C Pietra, G Villetti. Anticonvulsant preclinical profile of CHF 3381: dopaminergic and glutamatergic mechanisms. Pharmacology, biochemistry, and behavior. 2001 Sep; 70(1):157-66. doi: 10.1016/s0091-3057(01)00591-3. [PMID: 11566153]
  • G Villetti, G Bregola, F Bassani, M Bergamaschi, I Rondelli, C Pietra, M Simonato. Preclinical evaluation of CHF3381 as a novel antiepileptic agent. Neuropharmacology. 2001 Jun; 40(7):866-78. doi: 10.1016/s0028-3908(01)00026-0. [PMID: 11378157]